Articles

If you would like to be added to our newsletter, please send an email to mail@focalpointresearch.net with the subject line ‘Receive FPR Newsletter’.  

Washington’s new cosmetic law!

Washington’s new cosmetic law!

Washington State has introduced a new law under The Toxic-Free Cosmetics Act that could impact your product portfolio. Applicable from January 1, 2025, this law will restrict the manufacture, distribution, and sale of cosmetic products that contain one or more of...

read more
Health Canada to update Cosmetic Ingredient Hotlist for AHAs

Health Canada to update Cosmetic Ingredient Hotlist for AHAs

After six years of consultations and stakeholder engagement, Health Canada is proceeding with updating the Cosmetic Ingredient Hotlist for Alpha-Hydroxy Acids (AHAs). The proposed update aligns with the 2023 consultation proposal, with minor adjustments. AHAs were...

read more
MoCRA REMINDER!

MoCRA REMINDER!

As 2024 has kicked off, the FDA has geared up to enforce its MoCRA requirements for cosmetics. The extended deadline for facilities to submit cosmetic facility registrations and product listings on the FDA Cosmetics Direct portal continues to be July 01, 2024. If your...

read more
The DEL and MDEL renewal season is here! 

The DEL and MDEL renewal season is here! 

All DEL and MDEL holders, please be reminded that the deadline to submit your renewal applications this year is Mar. 31, 2024, in order to ensure compliance with regulatory requirements and continue with licensable activities. This process involves an annual fee...

read more
Summary Reports and Issue-related Analysis Reports

Summary Reports and Issue-related Analysis Reports

A Periodic Summary Reports is a comprehensive assessment of new information on the benefits and risks of a licensed Class II, III or IV medical device. Summary Reports are required by Health Canada for all medical devices. The reporting timeline for medical device...

read more
Medical Device Incident reporting

Medical Device Incident reporting

Health Canada requires the manufacturer and importer to submit both a preliminary and a final mandatory report constituting the details of any incident relating to the failure of a medical device or any inadequacy in its labelling or in its directions for use...

read more
Foreign Risk Notification (FRN)

Foreign Risk Notification (FRN)

Health Canada intends to improve the collection and assessment of new information relevant to the safety of a medical device in certain foreign jurisdictions to help determine an appropriate response in Canada to any risks reported. Per the Foreign Risk Notification...

read more
Health Canada Monograph Revisions Coming Soon!

Health Canada Monograph Revisions Coming Soon!

The Natural Non-Prescription Health Products Directorate (NNHPD) has an important update - they will begin revising all NHP monographs. The primary objective of the monograph revision initiative is to modernize the NHP monographs, ensuring they meet the new NHP...

read more

“Focal Point Research has consistently and professionally looked after regulatory and quality issues of our brand for years. Through a courteous and knowledgeable team, they have managed to navigate us through an ever changing regulatory landscape while maintaining our interests, and allowed us to correctly distribute and sell within Canada.”

“I have truly enjoyed working with you over the last 8 years! You and your team have been an amazing resource for me. I have always been impressed by the knowledge and professionalism of everyone at Focal Point, which is a true testament to your leadership.”

Connect With Us

The Focal Point Research team is ready to help with all of your scientific and regulatory needs.  Our team has the experience and expertise you need to see your product to market and we are eager to help you.